Teva to Host Conference Call to Discuss Second Quarter 2026 Financial Results on July 29, 2026 at 8 a.m. ET
Teva Pharmaceutical Industries Ltd. will release its second quarter 2026 financial results on July 29, 2026, followed by a conference call and webcast to discuss the report. The company, listed on the NYSE and TASE under ticker TEVA, continues its transformation into an innovative biopharmaceutical leader alongside its generics business.